0001420520 false 0001420520 2023-02-15 2023-02-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares









Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


Date of report (Date of earliest event reported): February 15, 2023





(Exact Name of Registrant as Specified in Its Charter)




Delaware 001-37850 30-0509586
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification Number)


750 University Avenue, Suite 280

Los Gatos, California 95032

(Address of principal executive offices)


(408) 442-5248

(Registrant’s telephone number, including area code)




(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common stock: Par value $0.001   ATOM   Nasdaq Global Market


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐






Item 2.02 Results of Operations and Financial Condition


On February 15, 2023, Atomera Incorporated issued a press release announcing its financial results for the three and twelve months ended December 31, 2022. The Company also intends to conduct an earnings call over which it will distribute an investor presentation. The text of the press release is attached hereto as Exhibit 99.1 and the investor presentation is attached hereto as Exhibit 99.2, both are incorporated by reference herein.


The information in this Current Report, including the exhibits attached hereto, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information in this Current Report on Form 8-K shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act regardless of any general incorporation language in such filing.


Item 9.01 Financial Statements and Exhibits


(d) Exhibits  


The following exhibits are filed with this report:


Exhibit Number Exhibit Description
99.1 Press release dated February 15, 2023 Atomera Incorporated
99.2 Investor presentation dated February 15, 2023 Atomera Incorporated
104 Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101).










Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


Dated: February 15, 2023 /s/ Francis B. Laurencio  

Francis B. Laurencio,

Chief Financial Officer




















Exhibit 99.1



Atomera Provides Fourth Quarter and Fiscal 2022 Results


LOS GATOS, Calif. Feb. 15, 2023 Atomera Incorporated (NASDAQ: ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the fourth quarter and fiscal year ended December 31, 2022.


Recent Company Highlights


Released a Whitepaper detailing Atomera’s contribution to advanced node technologies

One customer advanced into the integration phase (Phase Three)

Announced collaboration with Arizona State University to enable R&D aimed at advancing semiconductor materials


Management Commentary


“This point in the semiconductor industry cycle is ripe for Atomera to engage with customers on enhancing their process technologies and we are seeing a corresponding increase in customer interest,” said Scott Bibaud, President and CEO. “Recent efforts focused on technologies for the most advanced nodes have been garnering particularly strong interest from the industry.”


Financial Results


The Company incurred a net loss of ($4.3) million, or ($0.18) per basic and diluted share in the fourth quarter of 2022, compared to a net loss of ($4.2) million, or ($0.18) per basic and diluted share, for the fourth quarter of 2021. Adjusted EBITDA (a non-GAAP financial measure) in the fourth quarter of 2022 was a loss of ($3.5) million compared to an adjusted EBITDA loss of ($3.4) million in the fourth quarter of 2021.


For fiscal year 2022, revenue was $382,000, compared with $400,000 in fiscal 2021. Net loss was ($17.4) million, or ($0.75) per basic and diluted share for fiscal 2022, compared to ($15.7) million, or ($0.70) per basic and diluted share in fiscal 2021. Adjusted EBITDA for fiscal 2022 was a loss of ($14.1) million compared to an adjusted EBITDA loss of ($12.5) million in fiscal 2021.


The Company had $21.2 million in cash and cash equivalents as of December 31, 2022, compared to $28.7 million as of December 31, 2021.


The total number of shares outstanding was 24.0 million as of December 31, 2022.


Fourth Quarter and Fiscal Year 2022 Results Webinar


Atomera will host a live video webinar today to discuss its financial results and recent progress.

Date: Wednesday, Feb. 15, 2023

Time: 2:00 p.m. PT (5:00 p.m. ET)

Webcast: Accessible at https://ir.atomera.com








Note about Non-GAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.


About Atomera Incorporated

Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com


Safe Harbor

This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations or entered into a definitive royalty-based manufacturing and distribution license agreement with regard to our MST technology, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (3) risks related to our ability to advance the licensing arrangements with our initial integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 15, 2023. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.


-- Financial Tables Follow --











Atomera Incorporated

Balance Sheets

(in thousands, except per share data)



   December 31,   December 31, 
   2022   2021 
Current assets:          
Cash and cash equivalents  $21,184   $28,699 
Prepaid expenses and other current assets   418    309 
Total current assets   21,602    29,008 
Property and equipment, net   158    196 
Long-term prepaid maintenance and supplies   91    91 
Security deposit   14    14 
Operating lease right-of-use asset   700    900 
Financing lease right-of-use-asset   4,164    5,851 
Total assets  $26,729   $36,060 
Current liabilities:          
Accounts payable  $397   $338 
Accrued expenses   173    203 
Accrued payroll related expenses   967    601 
Current operating lease liability   245    216 
Current financing lease liability   1,126    1,395 
Total current liabilities   2,908    2,753 
Long-term operating lease liability   521    768 
Long-term financing lease liability   2,986    4,158 
Total liabilities   6,415    7,679 
Commitments and contingencies         
Stockholders’ equity:          
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding at December 31, 2022 and December 31, 2021        
Common stock: $0.001 par value, authorized 47,500 shares; 23,973 and 23,207 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively;   24    23 
Additional paid-in capital   203,585    194,212 
Accumulated deficit   (183,295)   (165,854)
Total stockholders’ equity   20,314    28,381 
Total liabilities and stockholders’ equity  $26,729   $36,060 








Atomera Incorporated

Statements of Operations

(in thousands, except per share data)



   Three Months Ended   Year Ended 
   December 31,   September 30,   December 31,   December 31, 
   2022   2022   2021   2022   2021 
   (Unaudited)   (Unaudited)   (Unaudited)         
Revenue  $5   $2   $   $382   $400 
Cost of revenue               (81)    
Gross margin   5    2        301    400 
Operating expenses                         
Research and development   2,523    2,743    2,249    10,038    8,779 
General and administrative   1,559    1,567    1,508    6,441    6,164 
Selling and marketing   329    347    316    1,348    986 
Total operating expenses   4,411    4,657    4,073    17,827    15,929 
Loss from operations   (4,406)   (4,655)   (4,703)   (17,526)   (15,529)
Other income (expense)                         
Interest income   189    113    2    340    9 
Interest expense   (55)   (60)   (76)   (255)   (128)
Total other income (expense), net   134    53    (74)   85    (119)
Net loss before income taxes   (4,272)   (4,602)   (4,147)   (17,441)   (15,648)
Provision for income taxes           18        66 
Net loss  $(4,272)  $(4,602)  $(4,165)  $(17,441)  $(15,714)
Net loss per common share, basic and diluted  $(0.18)  $(0.20)  $(0.18)  $(0.75)  $(0.70)
Weighted average number of common shares outstanding, basic and diluted   23,538    23,294    22,751    23,157    22,492 








Atomera Incorporated

Reconciliation to Non-GAAP EBITDA




   Three Months Ended   Year Ended 
   December 31,   September 30,   September 30,   December 31, 
   2022   2022   2021   2022   2021 
Net loss (GAAP)  $(4,272)  $(4,602)  $(4,165)  $(17,441)  $(15,714)
Depreciation and amortization   19    19    20    77    67 
Stock-based compensation   893    889    639    3,367    2,973 
Interest income   (189)   (113)   (2)   (340)   (9)
Interest expense   55    60    76    255    128 
Provision for income taxes           18        66 
Net loss non-GAAP EBITDA  $(3,494)  $(3,747)  $(3,414)  $(14,082)  $(12,489)






Investor Contact:

Bishop IR

Mike Bishop

(415) 894-9633


















Exhibit 99.2



Q4 2022 Conference Call February 15, 2023 Atomera Incorporated 1


Safe Harbor This presentation contains forward - looking statements concerning Atomera Incorporated (““Atomera,” the “Company,” “we,” “us,” and “our”). The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “woul d,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forwar d - looking statements. These forward - looking statements are subject to a number of risks, uncertainties and assumptions, including those disclosed in the section "Risk Factors" included in our Annual Report on Form 10 - K filed with the SEC on February 15, 2023 (the “Annual Report ”) . In light of these risks, uncertainties and assumptions, the forward - looking events and circumstances discussed in this presentation may not occur and actual results could differ materially and adversely from those anticipated or implied in our forward - looking statements. You should not rely upon forward - looking statements as predictions of future events. Although we believe that the expectations reflected in our forward - looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward - looking statements will be achieved or occur. This presentation contains only basic information concerning Atomera. The Company’s filings with the Securities Exchange Commission, including the Annual Report, include more information about factors that could affect the Company’s operating and financial results. We assume no obligation to update information contained in this presentation. Although this presentation m ay remain available on the Company's website or elsewhere, its continued availability does not indicate that we are reaffirming or confirming any of the information contained herein. Atomera Incorporated 2


3 Strong, Growing and Defensible Patent Portfolio High Leverage IP Licensing Business Model Top Tier Management Team Transistor enhancement technology for the $550B semiconductor market Mears Silicon Technology (MST®) Quantum Engineered Materials


Customer Pipeline 4 • 20 customers, 26 engagements • Working with 50% of the world’s top semiconductor makers* • 10 of the top 20 (IC Insights, McClean Report 2022) ^ End of year engagement count Atomera Confidential 0 5 10 15 20 25 30 2016 2017 2018 2019 2020 2021 1Q22 2Q22 3Q22 4Q22 Number of Customer Engagements Phase 4 Phase 3 Phase 2 Phase 1 v Customer Wafer Manufacturing Atomera MST ® Deposition Customer MST ® Deposition Phase 1 . Planning 2 . Setup 3 . Integration 4 . Installation 5 . Qualification 6 . Production 1/19/2023


MST: Solving GAA Transistor Challenges ► Blocks source/drain dopant diffusion ► Provides enhanced punch - through stop layer between source and drain Atomera Incorporated 5 ► Lowers contact resistance ► Reduces HKMG stack height ► Improves carrier mobility, gate leakage Transistor Architectural Evolution


MST technology focus areas 6 MST for Advanced Nodes MST for RF - SOI MST - SP Atomera Incorporated


Strong and Growing IP Portfolio Atomera Incorporated 7 Core MST Method and Device MST Enabled Devices/Architecture Next - Gen Architectures using MST Discoverable These distinctive layers are visible on products using MST Extensive know - how Extends life and value of patents 107 Foreign Patents 127 US Patents 76 Foreign 29 US 105 Pending 339 Patents Granted and Pending


Financial Review Atomera Incorporated 8 Income Statement ($ in thousands, except per-share data) 12/31/2022 12/31/2021 12/31/2022 9/30/2022 12/31/2021 REVENUE 382$ 400$ 5$ 2$ -$ Gross Profit 301 400 5 2 - OPERATING EXPENSES Research & Development 10,038 8,779 2,523 2,743 2,249 General and Administration 6,441 6,164 1,559 1,567 1,508 Selling and Marketing 1,348 986 329 347 316 TOTAL OPERATING EXPENSES 17,827 15,929 4,411 4,657 4,073 OPERATING LOSS (17,526) (15,529) (4,406) (4,655) (4,073) Other Income (Expense) 85 (119) 134 53 (74) Provision for income tax - (66) - - (18) NET LOSS (17,441)$ (15,714)$ (4,272)$ (4,602)$ (4,165)$ Net Loss Per Share (0.75)$ (0.70)$ (0.18)$ (0.20)$ (0.18)$ Weighted average shares outstanding 23,157 22,492 23,538 23,294 22,751 ADJUSTED EBITDA (NON-GAAP) (14,082)$ (12,489)$ (3,494)$ (3,747)$ (3,359)$ ADJUSTED EBITDA PER SHARE (0.61)$ (0.56)$ (0.15)$ (0.16)$ (0.15)$ Balance Sheet Information Cash 21,184$ 28,699$ 21,184$ 23,287$ 28,699$ Debt - - - - - Year Ended Three Months Ended


We collaborate with customers to improve their products, through integration of MST, so that both companies benefit financially Mission Statement Atomera Incorporated 9


Thank You Atomera Incorporated 10